Article and Video CATEGORIES

Cancer Journey

Search By

 

Dr. Aakash Desai, MBBS, MPH serves as an Assistant Professor of Medicine at the O'Neal Cancer Center, University of Alabama Birmingham. His pioneering research is primarily concentrated in the realm of evidence-based oncology, clinical trials, drug development, healthcare delivery, and quality of cancer care. He holds a particular interest in Thoracic Oncology and drug development.

Click here for more information about Dr. Desai. 

 

Program: LCVL 2023
Oncologists discuss a variety of topics in lung cancer, including biomarker testing, immunotherapy, KRAS+ disease, and emerging therapies, among other topics.

Author
Aakash Desai, MD, MPH - Guest Faculty
Image
LCVL 2023

In this latest update to the Lung Cancer Video Library, Oncologists discuss a variety of topics in lung cancer including biomarker testing, immunotherapy, KRAS+, emerging therapies, the changes that have occurred in treating NSCLC in the past few decades, Lung Cancer risk factors, and treatment options.

To watch the full playlist click here.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora